Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-08-24

Clinical Trial Update: Antiretroviral Therapy Intensification With Raltegravir or Addition of Hyper-immune Bovine Colostrum in HIV-1 Infected Patients With Suboptimal CD4+ T Cell Response [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluated antiretroviral therapy intensification with raltegravir or addition of hyper-immune bovine colostrum in HIV-1 infected patients with s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hyper-immune bovine colostrum
  • Isentress (Raltegravir)

Snippet

Sponsor: Kirby Institute | Conditions: HIV Infections | Phase 4 | Status: COMPLETED | Results posted: 2012-08-24